Xu and colleagues demonstrated that the combination of PEDF with radiotherapy enhances the efficacy of the antitumor effect on NPC by the coordinated inhibition on angiogenesis, which implies the potential role of PEDF as an adjuvant agent for NPC treatment [125]. This evidence concerns the gene SERPINF1 and nasopharyngeal carcinoma.